Full metadata record
DC FieldValueLanguage
dc.creatorMolero, J.M. (José María)-
dc.creatorMiñana, B. (Bernardino)-
dc.creatorPalacios-Moreno, J.M. (Juan Manuel)-
dc.creatorMartínez-Fornes, M.T. (Miguel Téllez)-
dc.creatorLorite-Mingot, D. (David)-
dc.creatorAgra-Rolán, A. (Alfonso)-
dc.creatorCarreño, Á. (Ágata)-
dc.creatorCuervo-Pinto, R. (Rafael)-
dc.identifier.citationMolero, J.M. (José María); Miñana, B. (Bernardino); Palacios-Moreno, J.M. (Juan Manuel); et al. "Real-world assessment and characteristics of men with benign prostatic hyperplasia (BPH) in primary care and urology clinics in Spain". International journal of clinical practice. 74 (11), 2020, e13602es
dc.description.abstractObjectives: To describe the real-world demographic and clinical characteristics of patients with lower urinary tract symptoms (LUTS) as a result of benign prostatic hyperplasia (BPH) in Spain. Methodology: This observational, retrospective, multicentre study conducted in primary care and urology clinics in Spain included men aged ≥50 years diagnosed (≤8 years prior to study visit) with LUTS caused by BPH. The primary endpoint was demographic and clinical characteristics; secondary endpoints included disease progression and diagnostic tests across both healthcare settings. Results: A total of 670 patients were included (primary care: n = 435; urology: n = 235). Most patients had moderate/severe LUTS (74.6%) and prostate volume >30 cc (81.7%), with no differences between settings. More patients had prostate-specific antigen (PSA) ≥1.5 ng/mL in primary care (74.5%) versus urology (67.7%). Progression criteria were prevalent (48.9%). Clinical criteria were more commonly used than the International Prostate Symptom Score (IPSS) to evaluate LUTS at diagnosis (primary care: clinical criteria 73.0%; IPSS: 26.9%; urology: clinical criteria 76.5%; IPSS: 23.4%). Proportion of patients with moderate/severe LUTS at diagnosis was lower using clinical criteria than IPSS, and the proportion of patients with 'worsening' LUTS (diagnosis to study visit) was higher when using clinical criteria versus IPSS. In both healthcare settings, the most commonly used diagnostic tests were general and urological clinical history and PSA. Conclusion: Demographic and clinical characteristics of patients with BPH in Spain were similar in primary care and urology; however, assessment criteria to evaluate LUTS severity differ and are not completely aligned with clinical guideline recommendations. Increased use of recommended assessments may enhance optimal BPH management.es_ES
dc.description.sponsorshipThis study was funded by GSK (study number 208444). The funder was involved in the study design, data collection, data analysis, manuscript preparation and decision to publish.es_ES
dc.subjectLower urinary tract symptoms (LUTS)es_ES
dc.subjectBenign prostatic hyperplasia (BPH)es_ES
dc.titleReal-world assessment and characteristics of men with benign prostatic hyperplasia (BPH) in primary care and urology clinics in Spaines_ES
dc.description.noteThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.es_ES
dadun.citation.publicationNameInternational journal of clinical practicees_ES

Files in This Item:
Int J Clinical Practice - 2020 - Mar a Molero - Real‐world assessment and characteristics of men with benign prostatic.pdf
838.23 kB
Adobe PDF

Statistics and impact
0 citas en
0 citas en

Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.